Creative Planning
GBT

Creative Planning’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Creative Planning’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,000
Closed -$119K – 2171
2020
Q1 		$119K Buy
+3,000
New +$201K ﹤0.01% 1495

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Creative Planning's GBT Position: Q2 2020 in Review

Creative Planning sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2020, closing a stake of 2,000 shares — an estimated $102K sold.

Creative Planning first reported a position in GBT in Q4 2015 and held it in 11 quarters. The position peaked at $3M in Q4 2018. 253 funds tracked by Wall St. Rank hold GBT as of Q2 2020.

  • Creative Planning reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Creative Planning sold 2,000 Global Blood Therapeutics, Inc. shares in Q2 2020, an estimated $102K.
  • Creative Planning first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 11 quarters.
  • Creative Planning's Global Blood Therapeutics, Inc. position peaked at $3M in Q4 2018.
  • 253 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2020.

Based on Creative Planning's 13F filing for Q2 2020, filed 23 Jul 2020.